Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134


Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro.

Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, Pedersen BK.

Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E155-62. Epub 2004 Sep 21.


On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.

Carpentier AC, Frisch F, Cyr D, Généreux P, Patterson BW, Giguère R, Baillargeon JP.

Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E849-56. Epub 2005 Jun 21.


Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans.

Hiscock N, Fischer CP, Sacchetti M, van Hall G, Febbraio MA, Pedersen BK.

Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E2-7. Epub 2005 Mar 1.


IL-6 selectively stimulates fat metabolism in human skeletal muscle.

Wolsk E, Mygind H, Grøndahl TS, Pedersen BK, van Hall G.

Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E832-40. doi: 10.1152/ajpendo.00328.2010. Epub 2010 Sep 7.


Characterization of the insulin-antagonistic effect of growth hormone in insulin-dependent diabetes mellitus.

Fowelin J, Attvall S, von Schenck H, Smith U, Lager I.

Diabet Med. 1995 Nov;12(11):990-6.


Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans.

Djurhuus CB, Gravholt CH, Nielsen S, Pedersen SB, Møller N, Schmitz O.

Am J Physiol Endocrinol Metab. 2004 Mar;286(3):E488-94. Epub 2003 Nov 4.


High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise.

Zderic TW, Davidson CJ, Schenk S, Byerley LO, Coyle EF.

Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E217-25. Epub 2003 Oct 14.


Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans.

van Loon LJ, Thomason-Hughes M, Constantin-Teodosiu D, Koopman R, Greenhaff PL, Hardie DG, Keizer HA, Saris WH, Wagenmakers AJ.

Am J Physiol Endocrinol Metab. 2005 Sep;289(3):E482-93. Epub 2005 May 10.


Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes.

Boden G, Cheung P, Mozzoli M, Fried SK.

Metabolism. 2003 Jun;52(6):753-9.


Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome.

D'Amico S, Shi J, Sekhar RV, Jahoor F, Ellis KJ, Rehman K, Willis J, Maldonado M, Balasubramanyam A.

Am J Clin Nutr. 2006 Jul;84(1):204-11.


Glucose regulation of lipid metabolism in humans.

Carlson MG, Snead WL, Hill JO, Nurjhan N, Campbell PJ.

Am J Physiol. 1991 Dec;261(6 Pt 1):E815-20.


Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.

Nielsen S, Møller N, Christiansen JS, Jørgensen JO.

Diabetes. 2001 Oct;50(10):2301-8.


Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.

Kashyap SR, Belfort R, Berria R, Suraamornkul S, Pratipranawatr T, Finlayson J, Barrentine A, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E537-46. Epub 2004 May 4.


Systemic and regional free fatty acid metabolism in type 2 diabetes.

Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD.

Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E1000-6.


Effect of rhIL-6 infusion on GH-->IGF-I axis mediators in humans.

Nemet D, Eliakim A, Zaldivar F, Cooper DM.

Am J Physiol Regul Integr Comp Physiol. 2006 Dec;291(6):R1663-8. Epub 2006 Jul 13.


Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.

Gastaldelli A, Casolaro A, Ciociaro D, Frascerra S, Nannipieri M, Buzzigoli E, Ferrannini E.

Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E225-30. doi: 10.1152/ajpendo.90960.2008. Epub 2009 May 5.


A circadian rhythm in lipid mobilization which is altered in IDDM.

Hagström-Toft E, Bolinder J, Ungerstedt U, Arner P.

Diabetologia. 1997 Sep;40(9):1070-8.


Supplemental Content

Support Center